Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDL.L Regulatory News (SDL)

  • There is currently no data for SDL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - AXA INVESTMENT MANAGERS: SDL PLC dealings

14 Sep 2020 14:43

Form 8.3 - AXA INVESTMENT MANAGERS: SDL PLC dealings

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:AXA Investment Managers S.A.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. 
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree SDL PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: 
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 11th September 2020
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A” YES: RWS Holdings PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 1p ordinary share
InterestsShort positions
 Number%Number%
(1) Relevant securities owned and/or controlled:3 294 3493.61%  
(2) Cash-settled derivatives:     
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL: AXA Investment Managers doesnot have discretion regardingvoting decisions in respect of1 552 613 shares that are included in this total. 3 294 349 3.61%  

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/sale Number of securitiesPrice per unit
1p ordinarySale1 816GBP 7.35
1p ordinarySale1 589GBP 7.33
1p ordinarySale10 536GBP 7.35
1p ordinarySale9 215GBP 7.33

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
     

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit
        

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
    

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)
    

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:14th September 2020
Contact name:Anthony Gilsoul
Telephone number*:+33 1 44 45 97 54

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
28th Oct 20148:58 amRNSDirector/PDMR Shareholding
15th Oct 20147:00 amRNSInterim Management Statement
29th Aug 20143:47 pmRNSTotal Voting Rights
21st Aug 20148:10 amRNSDirector/PDMR Shareholding
5th Aug 20147:00 amRNSHalf Yearly Report
11th Jul 201412:33 pmRNSNotice of Results
10th Jul 20144:53 pmRNSHolding(s) in Company
9th Jul 20142:12 pmRNSHolding(s) in Company
4th Jul 201412:02 pmRNSBlocklisting Interim Review
4th Jul 201411:38 amRNSTotal Voting Rights
25th Jun 20144:02 pmRNSHolding(s) in Company
18th Jun 201411:49 amRNSHolding(s) in Company
29th May 20143:30 pmRNSApplication for Admission & Exercise of Awards
15th May 20146:18 pmRNSTotal Voting Rights
2nd May 20147:00 amRNSHolding(s) in Company
1st May 20149:04 amRNSResult of AGM
29th Apr 20147:00 amRNSInterim Management Statement
14th Apr 20143:09 pmRNSAdditional Listing
8th Apr 20145:06 pmRNSAdditional Listing
7th Apr 20146:19 pmRNSDirector/PDMR Shareholding
4th Apr 20142:14 pmRNSHolding(s) in Company
31st Mar 20145:31 pmRNSTotal Voting Rights
18th Mar 20147:00 amRNSFinal Results
13th Mar 201410:46 amRNSApplication for Listing
27th Feb 201410:44 amRNSDirectorate Change
25th Feb 20142:17 pmRNSAnalyst and Investor Teach-in
21st Jan 20147:00 amRNSTrading Update
31st Dec 20139:39 amRNSBlocklisting Interim Review
30th Dec 20139:08 amRNSTotal Voting Rights
18th Dec 201311:39 amRNSHolding(s) in Company
16th Dec 20134:23 pmRNSDirector/PDMR Shareholding
13th Dec 20133:20 pmRNSHolding(s) in Company
25th Nov 20133:01 pmRNSDirectorate Change
20th Nov 20135:12 pmRNSHolding(s) in Company
19th Nov 20135:02 pmRNSHolding(s) in Company
15th Nov 20133:59 pmRNSHolding(s) in Company
6th Nov 201310:08 amRNSHolding(s) in Company
1st Nov 20139:42 amRNSTotal Voting Rights
23rd Oct 201310:54 amRNSHolding(s) in Company
22nd Oct 20133:43 pmRNSDirector/PDMR Shareholding
21st Oct 20132:30 pmRNSHolding(s) in Company
16th Oct 20135:52 pmRNSHolding(s) in Company
16th Oct 20133:53 pmRNSHolding(s) in Company
16th Oct 20133:49 pmRNSHolding(s) in Company
15th Oct 20137:00 amRNSInterim Management Statement
10th Oct 20136:05 pmRNSHolding(s) in Company
3rd Oct 20135:40 pmRNSHolding(s) in Company
1st Oct 20139:38 amRNSHolding(s) in Company
26th Sep 20137:00 amRNSDirectorate Change
23rd Sep 20133:51 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.